Collagen and Connective Tissue: What Randomized Trials Say About Joints and Tendons

Why does connective tissue recover slowly?

Tendons, ligaments, and articular cartilage consist primarily of collagen — a structural protein that gives tissues strength and elasticity. Unlike muscles, connective tissue has very low blood supply. This slows not only nutrient delivery but also matrix turnover: the half-life of collagen in the Achilles tendon is several years.

After acute loading or injury, fibroblast cells in tendons and chondrocytes in cartilage synthesize new collagen, but this process requires substrates. Proline and hydroxyproline — key amino acids for collagen synthesis — are present in sufficient quantities in hydrolyzed collagen and gelatin, but not in standard whey- or casein-based protein supplements.

How does ingested collagen reach the tissues?

It was long believed that proteins after digestion are broken down into amino acids and lose their specificity. However, research has shown that collagen dipeptides and tripeptides (Pro-Hyp, Hyp-Gly) are absorbed into the bloodstream intact and accumulate in cartilage and tendons, where they stimulate collagen synthesis by fibroblasts and chondrocytes.

The key question is the concentration of these precursors in the tissue at the time of loading. This is precisely what the Shaw group investigated.

What does the study on collagen synthesis in tendons show?

Shaw et al. (American Journal of Clinical Nutrition, 2017) conducted a crossover trial: participants took placebo, 5 g, or 15 g of gelatin enriched with vitamin C (50 mg) 1 hour before a six-minute jump training session. The level of P1NP — a collagen synthesis marker — was then measured in blood.

• 15 g gelatin: P1NP level after exercise was twice as high as in the placebo group (p<0.05).
• 5 g gelatin: intermediate effect, significantly higher than placebo.
• Vitamin C in this protocol is not a "bonus" but a required cofactor: without it, hydroxylation of proline — necessary for collagen cross-linking — is impossible.

Context matters: the study measured a biochemical marker, not clinical outcomes (pain, strength, function). Nevertheless, this is the first direct confirmation that the timing of collagen intake relative to exercise is biologically significant.

What do clinical trials say about osteoarthritis and joint pain?

Jiang et al. (PMC10505327, 2023) conducted a meta-analysis of 4 randomized trials with 507 knee osteoarthritis patients. Pain outcomes:

• Standardized mean difference (SMD) = −0.58 (95% CI: −0.98; −0.18), p = 0.004 — in favor of collagen.
• Post-hoc analysis including all pain measurements: SMD = −0.63 (95% CI: −0.86; −0.39), p < 0.00001.
• Adverse events: no significant differences between collagen and placebo in all 4 trials.

Limitation: the authors note a high risk of bias in all four studies. The effect is reproducible, the direction is stable, but sample sizes are small — larger rigorous trials are needed.

A more recent double-blind, placebo-controlled RCT (PMC11745964, 2025, 120 patients with grade II–III osteoarthritis, 10 g/day, 6 months) showed:

• Pain reduction (VAS): −43.6% in the collagen group vs −6.8% in the placebo group (p<0.001).
• CRP (inflammation marker) decreased by 56.2% in the collagen group (p<0.001).
• The proportion of patients needing NSAIDs decreased from 28.3% to 3.3% in the collagen group vs 71.7% → 41.7% in the placebo group.

Where is the evidence most compelling?

A 2025 systematic review (MDPI, Journal of Functional Morphology and Kinesiology) analyzed 8 RCTs in which collagen was combined with strength training. For increased tendon cross-sectional area at 15–30 g/day, the evidence level was GRADE A. This is the strongest conclusion from available data on collagen in an athletic context.

A systematic review of 14 joint trials (PMC11842160, 2025) showed that when objective assessment methods were used (MRI, biochemical markers), the rate of positive outcomes was lower (0.25) than with subjective measures (VAS pain, function). This is a typical pattern for supplements with moderate effect: subjective improvement is consistent, while objective structural changes require longer interventions and more sensitive tools.